Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Akcea Therapeutics Inc (NQ: AKCA)
29.27 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:11 PM EST, Dec 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 29.27
Bid (Size) 23.78 (1)
Ask (Size) 30.45 (1)
Prev. Close 29.27
Today's Range 29.27 - 29.27
52wk Range 15.23 - 40.75
Shares Outstanding 85,593,246
Dividend Yield N/A
Performance
YTD
+68.41%
+68.41%
1 Month
-1.31%
-1.31%
3 Month
+10.45%
+10.45%
6 Month
+12.88%
+12.88%
1 Year
+49.80%
+49.80%
Top News
More News
Consolidated Research: 2018 Summary Expectations for TD Ameritrade Holding, Supernus Pharmaceuticals, Akcea Therapeutics, Dell Technologies, iRobot, and Pegasystems — Fundamental Analysis, Key Perform
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of TD Ameritrade Holding... Read More
from GlobeNewswire News Releases
Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting
Presentations focus on the benefits of treatment with TEGSEDI™ (inotersen) and results show continued efficacy with long-term exposure in the NEURO-TTR open-label extension study Read More
from GlobeNewswire News Releases
More News
Read More
Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions
from GlobeNewswire News Releases
Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions
from GlobeNewswire News Releases
Akcea Therapeutics to Present at Upcoming Investor Conferences
from GlobeNewswire News Releases
Akcea Reports Financial Results and Highlights for Third Quarter 2018
from GlobeNewswire News Releases
Akcea Recognizes First Global Familial Chylomicronemia Syndrome (FCS) Awareness Day
from GlobeNewswire News Releases
Investor Expectations to Drive Momentum within Adient, BT Group, The Kraft Heinz, Teladoc, Oracle, and Akcea Therapeutics — Discovering Underlying Factors of Influence
from GlobeNewswire News Releases
Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast
from GlobeNewswire News Releases
Noteworthy Monday Option Activity: TELL, CSTE, AKCA
category Stocks
from Market News Video
Notable Thursday Option Activity: FDX, BBBY, AKCA
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.